摘要
目的提高光动力治疗药物5-氨基酮戊酸(ALA)的脂溶性从而增强其透皮吸收效果。方法制备ALA的磷脂(PC)复合物(ALA-PC);差示量热扫描法(DSC)研究其热力学性质;通过测定油水分配系数POCT/PBS、体外渗透试验和小鼠经皮给药试验,比较ALA和ALA-PC的透皮效果。结果ALA与PC的复合率为99.6%;DSC图谱表明ALA-PC是不同于ALA、PC、ALA与PC的物理混合物(ALA+PC)的新物相;ALA-PC的油水分配系数为ALA的7.8倍;与ALA相比,ALA-PC的表观渗透系数显著增加且在正常小鼠皮肤内诱导产生的原卟啉IX(PpIX)的量和透过深度均提高。结论ALA-PC可提高ALA的脂溶性和透皮效果,有望成为透皮给药进行光动力治疗的有效药物。
Abstract
OBJECTIVE To increase the transdermal ratio of ALA through its phospholipid compound(ALA-PC) which possesses enhanced lipophilicity.METHODS ALA-PC was prepared.The thermodynamics properties of ALA-PC were studied by DSC.Oil-water partition coefficient(PO/W),in vitro permeation and in vivo transdermal experiments were conducted to study the lipophilicity and transdermal properties of ALA-PC.RESULTS A compound ratio of 99.6% was obtained.Some new peaks appeared in the DSC spectra of ALA-PC,as compared with ALA,PC and ALA+PC.The PO/W of ALA-PC was 7.8 times as that of ALA,while in vitro apparent permeability coefficient of ALA-PC increased significantly.More PpIX was induced by ALA-PC in normal mice skin,which existed in the deeper area.CONCLUSION ALA-PC was confirmed to be a new substance.The transdermal ability of ALA was improved after being complexed with PC.The results suggested that ALA-PC would be a promising transdermal delivery drug for photodynamic therapy.
关键词
5-氨基酮戊酸 /
磷脂复合物 /
透皮给药 /
光动力治疗
{{custom_keyword}} /
Key words
5-aminolevulinic acid /
phospholipid compound /
transdermal delivery /
photodynamic therapy
{{custom_keyword}} /
杨昀;马炯;王玉华;印春华.
5-氨基酮戊酸磷脂复合物的研究[J]. 中国药学杂志, 2007, 42(01): 36-39
YNG Yun;M Jiong;WNG Yu-hu;YIN Chun-hu.
Studies on the Compounds of 5-Aminolevulinic Acid and Phospholipid [J]. Chinese Pharmaceutical Journal, 2007, 42(01): 36-39
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] NINOMIYA Y，ITOH Y，JAJIMA S，et al. In vitro and in vivo expression of protoporphyrin IX induced by lipophilic 5-aminolevulinic acid derivatives [J] .J Dermatol Sci，2001，27(2)：114-120.
[2] GIERSKCKY K E，MOAN J，PENG Q，et al. Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherpy：USA，6492420[P] . 2002-12-10.
[3] MALIK Z，KOSTENICH G，ROITMAN L，et al. Topical application of 5-aminolevulinic acid，DMSO and EDTA：protoporphyrin IX accumulation in skin and tumours of mice [J] .J Photochem Photobiol B，1995，28(3)：213-218.
[4] NADIA M，TOBIAS B，KATARINA E. Iontophoretic delivery of 5-aminolevulinic acid and its methyl ester using a carbopol gel as vehicle [J] .J Controlled Release，2004，98(1)：57-65.
[5] WU J M，CHEN D W，SUN B，et al. Natural active complexes with phospolipids [J] .Chin Pharm J(中国药学杂志)，1998，33(1)：9-11.
[6] ZHAI G X，LOU H X，ZOU L J，et al. Progress on studies of drug-phospholipid complexes [J] .Chin Pharm J(中国药学杂志)，2001，36(12)：800-803.
[7] WEN H Z，FAN M G. Determination of δ- Aminolevulinic Acid by Spectrophotometry [J] .Tech Devel Chem Ind (化工技术与开发)，1997，26(2):47-50.
[8] IROTAKA O，HIROKO N，KAZUO N，et al. Fluorometric HPLC determination of δ- aminolevulinic acid (ALA) in the plasma and urine of lead workers：biological indicators of lead exposure [J] .J Anal Toxicol，1996，20：106-110.
[9] ZHU J.Laser Medical (激光医学)[M] ．Shanghai：Shanghai Science and Technology Press，2003：131-135.
[10] ROSA F S，DMARCHETTI J M，THOMAZINI J A，et al. A vehicle for photodynamic therapy of skin cancer：influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy [J] .J Controlled Release，2000，65(3)：359-366.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
